In the later stages of tumorigenesis, tumor-promoting effects of stromal TGFβ signaling can occur independently of epithelial cancer cells, in which TGFβ pathway components, such as SMAD4 and TGFΒR2, are often mutationally inactivated [16]. This evidence concerns the gene SMAD4 and cancer.